Today we have a BIG new!
We want to announce that the protocol and documents for the phase II clinical trial of OXO-001 have already been submitted to the three corresponding Regulatory Agencies and Ethics Committees. We have achieved a very important milestone, but mainly, we are closer to the start of OXOART 2, the OXO-001 phase II clinical trial.
#growwithus